Pfizer, BioNTech say COVID-19 booster highly effective
Pfizer and BioNTech said a booster shot of their COVID-19 vaccine restored efficacy to 95.6% against the virus, including the Delta variant, according to data from a Phase III trial.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook